Previous 10 | Next 10 |
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event. For further details see: Amphastar Pharmaceuticals (AMPH) Presents At 20th Annual Needham Virtual Healthcare Conference
RANCHO CUCAMONGA, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Exe...
The FDA has approved Amphastar Pharmaceuticals' (AMPH) Abbreviated New Drug Application ((ANDA)) for Dextrose injection 50% in the 50 mL Luer-Jet Prefilled Syringe System.For the past 40 years, the company has sold and marketed the product under the “grandfather” exception ...
RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s Abbreviated New Drug Application (“ANDA”) for Dextrose injection...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q4 2020 Earnings Call Mar 15, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Amphastar Pharmaceuticals Inc (AMPH) Q4 2020 Earnings Call Tr...
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2020 Results Conference Call March 15, 2021 5:00 PM ET Company Participants Dan Dischner - Vice President of Corporate Communications Bill Peters - Chief Financial Officer, Treasurer, and Senior Vice President of Finance Conference Call Participants T...
Amphastar Pharmaceuticals (AMPH): Q4 Non-GAAP EPS of $0.16 beats by $0.02; GAAP EPS of -$0.13.Revenue of $95.92M (+15.0% Y/Y) beats by $6.98M.The Company currently has five ANDAs on file with the FDA targeting products with a market size of approximately $2.3 billion, three biosimilar product...
RANCHO CUCAMONGA, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months and full-year ended December 31, 2020. Fourth Quarter Highlights ...
RANCHO CUCAMONGA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2020 ended December 31, 2020, after the market closes on Monday, March 15th, 2021, and will hold a conference...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event. For further details see: Amphastar Pharmaceuticals (AMPH) Presents At Raymond James 42nd Annual Institutional Investors Conference - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...